Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:35 PM UTC
| NCT Number | NCT06855277 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE3 |
| Target Enrollment | 940 participants |
| Active Locations | 38 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | September 22, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT06855277 is currently recruiting participants. This phase3 study for prostate cancer is actively seeking new participants at 38 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06855277 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 38 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06855277 was last updated 2 weeks ago (September 22, 2026). HelloStudys verifies this status automatically.